Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Abrupt cessation wont cause withdrawal symptoms or rebound effects, but metabolic markers will gradually return to baseline over 24 weeks as AMPK activity normalizes and NNMT inhibition wears off
Patients are advised to obtain these medications from reputable sources, as the FDA (Food and Drug Administration) has expressed concerns about compounded versions of the drug
Priority Applications (5) Applications Claiming Priority (2) Publications (1) Family ID=88518003 Family Applications (1) Country Status (7) Cited By (5) Families Citing this family (3) Citations (5) Family Cites Families (9) 2023 2023-04-28 CN CN202380037101.3A patent/CN120129529A/en active Pending 2023-04-28 US US18/849,043 patent/US20250205311A1/en active Pending 2023-04-28 WO PCT/IB2023/054435 patent/WO2023209662A1/en not_active Ceased 2023-04-28 EP EP23795768.3A patent/EP4514376A4/en active Pending 2023-04-28 TW TW112116103A patent/TW202400219A/en unknown 2023-04-28 AU AU2023262714A patent/AU2023262714B2/en active Active 2023-04-28 CA CA3252426A patent/CA3252426A1/en active Pending
Diabetes Care (2019) 42:226271
US$ 23.13
US$ 28.96
US$ 23.85
US$ 28.13
US$ 21.18
